Halper Sadeh LLC Investigates BOLD and NDRA Mergers for Shareholder Fairness

GlobeNewswire··Read original
2▲0 ▼2Impact / 5
Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating Boundless Bio and ENDRA Life Sciences over their proposed mergers, citing concerns that shareholders may not be receiving fair deals. The firm says insiders could obtain substantial financial benefits not available to ordinary shareholders, and the transactions may contain terms that limit superior competing offers. Boundless Bio shareholders are expected to own approximately 3.7% of the combined company after its merger with Serapha Bio, while ENDRA shareholders would hold about 3% following its merger with Noble Africa. Halper Sadeh may seek increased consideration or additional disclosures on behalf of shareholders, and encourages them to contact the firm at no cost to discuss their rights.

Impact on assets 2

Biotech & Genomic Medicine▼ · 2 stocks
ENDRA Life Sciences Inc
NDRA
▼ NegativeRegulationrelevance

Investigation into merger fairness may lead to increased scrutiny or deal changes, harming shareholders.

Off-coverage companies 2

Noble Africa LLCPrivate± Mixed
relevance

Serapha BioPrivate± Mixed
relevance

© 2026 MarketIVNews